» Articles » PMID: 21339765

Methods for Making Induced Pluripotent Stem Cells: Reprogramming à La Carte

Overview
Journal Nat Rev Genet
Specialty Genetics
Date 2011 Feb 23
PMID 21339765
Citations 220
Authors
Affiliations
Soon will be listed here.
Abstract

Pluripotent stem-cell lines can be obtained through the reprogramming of somatic cells from different tissues and species by ectopic expression of defined factors. In theory, these cells--known as induced pluripotent stem cells (iPSCs)--are suitable for various purposes, including disease modelling, autologous cell therapy, drug or toxicity screening and basic research. Recent methodological improvements are increasing the ease and efficiency of reprogramming, and reducing the genomic modifications required to complete the process. However, depending on the downstream applications, certain technologies have advantages over others. Here, we provide a comprehensive overview of the existing reprogramming approaches with the aim of providing readers with a better understanding of the reprogramming process and a basis for selecting the most suitable method for basic or clinical applications.

Citing Articles

[C6TSEDRVAJZ, a combination of small-molecule compounds, induces differentiation of human placental fibroblasts into epithelioid cells ].

Dai Z, Gao Q, Ying M, Wang A, Hong J, Wang C Nan Fang Yi Ke Da Xue Xue Bao. 2025; 45(2):322-330.

PMID: 40031976 PMC: 11875853. DOI: 10.12122/j.issn.1673-4254.2025.02.13.


Modeling ALS with Patient-Derived iPSCs: Recent Advances and Future Potentials.

Dawoody Nejad L, Pioro E Brain Sci. 2025; 15(2).

PMID: 40002468 PMC: 11852857. DOI: 10.3390/brainsci15020134.


Targeting CREB-binding protein (CBP) abrogates colorectal cancer stemness through epigenetic regulation of C-MYC.

Chung D, Wang C, Liu P, Ng S, Luo C, Jwo S Cancer Gene Ther. 2024; 31(11):1734-1748.

PMID: 39358564 DOI: 10.1038/s41417-024-00838-9.


Manipulating cell fate through reprogramming: approaches and applications.

Yagi M, Horng J, Hochedlinger K Development. 2024; 151(19).

PMID: 39348466 PMC: 11463964. DOI: 10.1242/dev.203090.


iPSC-Derived Cardiomyocytes as a Disease Model to Understand the Biology of Congenital Heart Defects.

Pushpan C, Kumar S Cells. 2024; 13(17.

PMID: 39273002 PMC: 11393881. DOI: 10.3390/cells13171430.


References
1.
Hotta A, Ellis J . Retroviral vector silencing during iPS cell induction: an epigenetic beacon that signals distinct pluripotent states. J Cell Biochem. 2008; 105(4):940-8. DOI: 10.1002/jcb.21912. View

2.
Takahashi K, Okita K, Nakagawa M, Yamanaka S . Induction of pluripotent stem cells from fibroblast cultures. Nat Protoc. 2007; 2(12):3081-9. DOI: 10.1038/nprot.2007.418. View

3.
Li W, Zhou H, Abujarour R, Zhu S, Joo J, Lin T . Generation of human-induced pluripotent stem cells in the absence of exogenous Sox2. Stem Cells. 2009; 27(12):2992-3000. PMC: 3780784. DOI: 10.1002/stem.240. View

4.
Ellis J, Bruneau B, Keller G, Lemischka I, Nagy A, Rossant J . Alternative induced pluripotent stem cell characterization criteria for in vitro applications. Cell Stem Cell. 2009; 4(3):198-9. DOI: 10.1016/j.stem.2009.02.010. View

5.
Silva J, Barrandon O, Nichols J, Kawaguchi J, Theunissen T, Smith A . Promotion of reprogramming to ground state pluripotency by signal inhibition. PLoS Biol. 2008; 6(10):e253. PMC: 2570424. DOI: 10.1371/journal.pbio.0060253. View